Registering a CAGR of 6.5% over the forecast period, the market value of Hemostatic Agents is expected to reach US$ 56400 million in the year 2027.
The rising prevalence of chronic diseases in the geriatric population is driving up demand for hemostasis agents. Because of the rise in surgical procedures around the world, there will be a high demand for hemostasis agents, propelling the hemostasis agents’ market. Furthermore, the increase in the number of products with technological advancements contributes to market growth. The Global Hemostatic Agents Market report offers a comprehensive analysis of the market. The report provides a thorough examination of key segments, trends, drivers, restraints, the competitive landscape, and factors that are significant in the market.
The surge in the number of surgical procedures performed globally has provided impetus to give a strong boost to the rising incidence of bleeding complications during surgeries. In the current scenario, there is a wide range of medical instruments available for management, as well as a significant improvement in the achievement of hemostasis in surgical procedures. According to recent estimates published by the National Center for Biotechnology Information (NCBI), approximately 60-70 percent of all transfused red blood cells are used in a surgical setting, as bleeding during surgery is one of the most feared complications that can occur during these procedures. This has resulted in a significant demand for the product offerings in the global market, as many surgeons prefer to use these products in surgical procedures with a low risk of bleeding complications.
The global Hemostatic Agents includes the identification and analysis of the various market participants competing in the global market. Prominent competitors include Ethicon, Pfizer, Baxter International, C. R. Bard, The Medicines Company, Anika Therapeutics, Advanced Medical Solutions, Integra LifeSciences, B Braun Melsungen, Gelita Medical, Equimedical, Vascular Solutions, Marine Polymer Technologies, Z-Medica, CryoLife, BioCer Entwicklungs, BiomUp SAS and others.
Industry News and Updates:
Medcura raises $7.4 million to upgrade its FDA-approved line of hemostats and wound dressings.
12 August 2021 – Medcura, Inc., a commercial-stage medical device company, announced today that it has raised $7.4 million in private equity to support its expanding product line and the clinical development of its lead surgical candidate. The financing includes the sale of Series A Preferred stock as well as common stock, which was made possible in part by certain investors who took advantage of a Maryland Investment Incentive Program.
The market is segmented based on the type, applications, companies, and regions.
By Type, it is segmented into
By Application, it is segmented into
North America controls the majority of the global market and is expected to maintain its dominance by the end of the forecast period. Some of the key factors driving market growth in the United States are an increase in the number of surgical procedures, an increase in patient population, the presence of key players and products, and a h3 focus on research and development activities. Rising medical tourism and surgical procedures, as well as an increasing patient population opting for minimally invasive procedures, are expected to present a lucrative growth scenario for the hemostatic agents market in this region.
The Hemostatic Agents Market describes the factors driving the global growth opportunities in upcoming years and highlights market channels. In addition, the report analyzes market size and share, trends, by geographic region, end-use type, and segment. It focuses extensively on revealing a detailed regional analysis. The Global Hemostatic Agents Market report also conducted a PESTEL analysis of the industry to study the main influencing factors and entry barriers of the industry.
Report Attributes | Report Details |
Report Title | Hemostatic Agents Market - Growth, Trends And Forecast (2022 - 2027) By Types, By Application, By Regions and By Key Players: Ethicon, Pfizer, Baxter International, C. R. Bard |
Forecast Period 2022 to 2027 CAGR | CAGR of 6.5% over the forecast period (2022-2027) |
By Type |
|
By Application |
|
By Companies | Ethicon, Pfizer, Baxter International, C. R. Bard, The Medicines Company, Anika Therapeutics, Advanced Medical Solutions, Integra LifeSciences, B Braun Melsungen, Gelita Medical, Equimedical, Vascular Solutions, Marine Polymer Technologies, Z-Medica, CryoLife, BioCer Entwicklungs, BiomUp SAS |
Regions Covered |
|
Countries Covered |
|
Base Year | 2022 |
Historical Year | 2017 to 2021 |
Forecast Year | 2022 to 2027 |
Number of Pages | 122 |
Customization Available | Yes, the report can be customized as per your needs |
What is the study period of this market?
The Hemostatic Agents Market is studied from 2017 - 2027.
What is the growth rate of the Hemostatic Agents Market?
The Hemostatic Agents Market is growing at a CAGR of 6.5% over the next 5 years.
Who are the key players in Hemostatic Agents Market?
Ethicon, Pfizer, Baxter International, C. R. Bard, The Medicines Company, Anika Therapeutics, Advanced Medical Solutions, Integra LifeSciences, B Braun Melsungen, Gelita Medical, Equimedical, Vascular Solutions, Marine Polymer Technologies, Z-Medica, CryoLife, BioCer Entwicklungs, BiomUp SAS
What regions does this Hemostatic Agents Market report cover?
North America (the United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, and Italy)
Asia-Pacific (China, Japan, Korea, India, and Southeast Asia)
South America (Brazil, Argentina, Colombia, etc.)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, and South Africa)
What are the significant types of Hemostatic Agents Market?
Gelation Sponge, Oxidized Regenerated Cellulose Based Hemostats, Others
What are the major end-use applications of Hemostatic Agents Market?
Hospitals, Surgical Centers, Nursing Homes
All our reports are custom made to your company’s needs to a certain extent, we do provide 5 free consulting hours along with the purchase of each report, and this will allow you to request any additional data to customize the report to your needs.
SECONDARY RESEARCH
Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.
PRIMARY RESEARCH
Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.
MARKET ENGINEERING
The market engineering phase involves analyzing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.
EXPERT VALIDATION
The market engineered data is verified and validated by a number of experts, both in-house and external.
REPORT WRITING/ PRESENTATION
After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.
Reach us with your research requirements and we shall provide the optimum solution to suit your needs.
Discounts available for multiple report purchases.